Chronic Myeloid Leukemia: What HCPs Need to Know

Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI

2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Understanding Waldenström Macroglobulinemia

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA

CAR T-cell Therapy in Review 2022: Updates in Treatment

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX

Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC

AML: Insights, Updates, and Takeaways

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY